Skip to main content

Yellow fever: Tychan develops 1st antibody candidate treatment

Submitted by lsekela on November 15, 2019 - 08:23 AM

Tychan‘s monoclonal antibody candidate treatment for Yellow Fever has successfully completed Phase 1A/1B safety trials in Singapore.

Content Source:

Outbreak News Today

Content Author:

unknown

Tags: